Editorial: Targeting JAM-C on mantle cell lymphoma B cells: time for clinical testing?
- PMID: 27799440
- DOI: 10.1189/jlb.5CE0616-247R
Editorial: Targeting JAM-C on mantle cell lymphoma B cells: time for clinical testing?
Keywords: B cell malignancy; adhesion molecule; monoclonal antibody; therapeutic targeting.
Comment on
-
Anti-JAM-C therapy eliminates tumor engraftment in a xenograft model of mantle cell lymphoma.J Leukoc Biol. 2016 Nov;100(5):843-853. doi: 10.1189/jlb.1HI1114-549RR. Epub 2016 Jun 2. J Leukoc Biol. 2016. PMID: 27256571
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
